A total of 603 samples, from 600 patients, were received for BRCA1/2 tumor testing at UHN within the study period, including 518 surgical resections (2 from distant sites), 81 biopsies, 2 cytology samples, and 2 with unknown origin. Here, BRCA1 is linked to neoplasm.